Author of the publication

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and . Breast cancer research : BCR, 13 (6): R110 (2011)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers, , , , , , , , , and 171 other author(s). Breast cancer research : BCR, 14 (1): R33 (2012)Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 127 other author(s). Human molecular genetics, 18 (22): 4442–4456 (2009)Whole-genome sequencing of patients with rare diseases in a national health system., , , , , , , , , and 439 other author(s). Nat., 583 (7814): 96-102 (2020)Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2, , , , , , , , , and 172 other author(s). Breast cancer research : BCR, 13 (6): R110 (2011)Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 169 other author(s). Human molecular genetics, 20 (16): 3304–3321 (2011)Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers, , , , , , , , , and 63 other author(s). Breast cancer research : BCR, 12 (6): R102 (2010)Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 176 other author(s). Human mutation, 33 (4): 690–702 (2012)Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction, , , , , , , , , and 168 other author(s). Cancer research, 70 (23): 9742–9754 (2010)Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts, , , , , , , , , and 26 other author(s). Gut, 62 (6): 812–823 (2013)Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?, , , , , and . BMC Medical Informatics Decis. Mak., (2014)